Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.
Gross Profit (ttm)
Diluted EPS (ttm)
Mr. Eric Weisblum Chairman, Pres, Chief Compliance Officer, CEO & CFO